India, Sept. 23 -- Cardiometabolic disease refers to a group of closely linked conditions that affect heart and metabolic health, including heart disease, stroke, type 2 diabetes and non-alcoholic fat... Read More
India, Sept. 22 -- On Tuesday, Here Group Limited (HERE), a toy company, reported a loss in the fourth quarter of 2026, compared to the profit in the same quarter last year, due to higher operating ex... Read More
India, Sept. 22 -- InnovAge Holding Corp. (INNV), a provider of comprehensive healthcare programs, announced the pricing of a secondary offering of its common stock by selling stockholders. Investmen... Read More
India, Sept. 22 -- AutoZone, Inc. (AZO) is up 4.99 percent, gaining $140.13 to $2,943.38 on Tuesday. The move comes after the auto-parts retailer reported fourth-quarter earnings of $931.587 million, ... Read More
India, Sept. 22 -- Vertex Pharmaceuticals Inc. (VRTX) reported positive Phase 2b results for Inaxaplin in additional groups of patients with APOL1-mediated kidney disease (AMKD), while also announcing... Read More
India, Sept. 22 -- CNSide Diagnostics, LLC, a wholly owned subsidiary of Cerenome, Inc. (CNSY), a CNS oncology company, announced that it has signed an in-network provider agreement with Blue Cross Bl... Read More
India, Sept. 22 -- Shares of LPL Financial Holdings Inc. (LPLA) are falling around 7 percent on Tuesday morning after it announced that the financial advisors of Cornerstone Advisors and Clear Pointe ... Read More
India, Sept. 22 -- TriSalus Life Sciences, Inc. (TLSI), an oncology-focused medical technology company, said the U.S. Food and Drug Administration has granted 510(k) clearance to TriNav Advance, expan... Read More
India, Sept. 22 -- Dantax A/S (DANT.CO) announced a profit for its full year that Increased, from the same period last year The company's earnings came in at DKK7.58 million, or DKK25.3 per share. Th... Read More
India, Sept. 22 -- Polyrizon Ltd. (PLRZ), a clinical-stage biotechnology company, on Tuesday announced the enrollment of the first patient in a clinical study assessing NASARIX to treat seasonal aller... Read More